CEL-SCI Stock (AMEX: CVM) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 6.000 / 308.459K |
Day Range | - - - |
52 Wk Range | 1.040 - 3.230 |
Market Cap | $78.297M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | AMEX |
RSI | 30 |
Short Interest | 13.1% |
Days to Cover | 19.67 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of CEL-SCI (AMEX: CVM) through any online brokerage.
Other companies in CEL-SCI’s space includes: HOOKIPA Pharma (NASDAQ:HOOK), Connect Biopharma Hldgs (NASDAQ:CNTB), CARISMA Therapeutics (NASDAQ:CARM), Burning Rock Biotech (NASDAQ:BNR) and Gritstone Bio (NASDAQ:GRTS).
The latest price target for CEL-SCI (AMEX: CVM) was reported by EF Hutton on Wednesday, July 12, 2023. The analyst firm set a price target for 10.00 expecting CVM to rise to within 12 months (a possible 589.42% upside). 1 analyst firms have reported ratings in the last year.
The stock price for CEL-SCI (AMEX: CVM) is $1.4505 last updated April 24, 2024 at 9:08 AM EDT.
There are no upcoming dividends for CEL-SCI.
CEL-SCI’s Q2 earnings are confirmed for Friday, May 10, 2024.
There is no upcoming split for CEL-SCI.
CEL-SCI is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.